Inhaled amikacin as a preventive strategy against ventilator-associated pneumonia in a trauma intensive care unit: early evidence from a single-center retrospective cohort study
Prophylactic inhaled amikacin neither prevented nor increased IVAC and VAP risk in mechanically ventilated trauma patients, suggesting no meaningful impact on VAP outcomes in this population.
Authors
- Younghwan Kim (ORCID: https://orcid.org/0000-0001-8225-3340)
- Gaesung Ha (ORCID: https://orcid.org/0000-0002-4609-3754)
- Youngwoong Kim (ORCID: https://orcid.org/0000-0002-4824-5328)
- Myungwoong Kim (ORCID: https://orcid.org/0000-0003-0611-8694)
- Seok Hwa Youn (ORCID: https://orcid.org/0000-0001-5983-3056)
- Ohchul Kwon
- Jinho Jheong
- Nahyeon Lee
Institutions
- Seoul National University Bundang Hospital (KR)
- National Medical Center (KR)
Publication Details
- Journal
- Journal of Trauma and Injury
- Published
- 2025-12-31
- DOI
- https://doi.org/10.20408/jti.2025.0145
- Primary Topic
- Nosocomial Infections in ICU
- Type
- article
- Field-Weighted Citation Impact
- 0.00